|
"liu cj"的相關文件
顯示項目 91-100 / 146 (共15頁) << < 5 6 7 8 9 10 11 12 13 14 > >> 每頁顯示[10|25|50]項目
| 國立臺灣大學 |
2007-11 |
Hepatitis B viral genotype: what should the clinicians know?
|
Liu, CJ; Kao, JH. |
| 國立臺灣大學 |
2007-11 |
Hepatitis B viral factors in HBeAg-negative carriers with persistently normal serum alanine aminotransferase levels.
|
Lin, CL; Liao, LY; Liu, CJ; Yu, MW; Chen, PJ; Lai, MY; Chen, DS; Kao, JH. |
| 國立臺灣大學 |
2007-11 |
Clinicopathological differences between Hepatitis B viral genotype B and C-related resectable hepatocellular carcinoma.
|
Lin, CL; Chen, JD; Liu, CJ; Lee, PH; Chen, PJ; Lai, MY; Kao, JH; Chen, DS. |
| 國立臺灣大學 |
2007-11 |
Hepatitis B virus-related hepatocellular carcinoma: epidemiology and pathogenic role of viral factors.
|
Liu, CJ; Kao, JH. |
| 臺大學術典藏 |
2007-11 |
Hepatitis B virus-related hepatocellular carcinoma: epidemiology and pathogenic role of viral factors.
|
Liu, CJ;Kao, JH.; Liu, CJ; Kao, JH. |
| 國立臺灣大學 |
2007-10 |
Noninvasive diagnosis of hepatic fibrosis in patients with chronic hepatitis C by splenic Doppler impedance index.
|
Liu, CH; Hsu, SJ; Lin, JW; Hwang, JJ; Liu, CJ; Yang, PM; Lai, MY; Chen, PJ; Chen, JH; Kao, JH; Chen, DS. |
| 國立臺灣大學 |
2007-09 |
Subgenotypes of hepatitis B virus genotype C do not correlate with disease progression of chronic hepatitis B in Taiwan.
|
Tseng, TC; Liu, CJ; Chen, PJ; Lai, MY; Lin, CL; Kao, JH; Chen, DS. |
| 國立臺灣大學 |
2007-04 |
Hepatitis B viral factors in HBeAg-Negative carriers with persistently normal serum alanine aminotransferase levels.
|
Lin, CL; Liao, LY; Liu, CJ; Yu, MW; Chen, PJ; Lai, MY; Chen, DS; Kao, JH. |
| 國立臺灣大學 |
2007-02 |
Interferon-based therapy for dialysis patients with chronic hepatitis C: progress and challenges.
|
Liu, CH; Liu, CJ; Kao, JH. |
| 國立臺灣大學 |
2007-01 |
Early viral kinetics during treatment of chronic hepatitis C virus infection with pegylated interferon alpha plus ribavirin in Taiwan.
|
Hsu, CS; Liu, CJ; Lai, MY; Chen, PJ; Kao, JH; Chen, DS. |
顯示項目 91-100 / 146 (共15頁) << < 5 6 7 8 9 10 11 12 13 14 > >> 每頁顯示[10|25|50]項目
|